摩根大通发表研究报告指,礼来(LLY.US) 宣布与金斯瑞生物科技(01548.HK) 等达成TuneLab合作协议,其中金斯瑞将为TuneLab成员公司提供湿实验室服务,包括基因合成、蛋白质表达、净化及按标准化协议进行测试,协助把人工智能生成的药物候选转化为实验结果,认为有助于强化金斯瑞的AI驱动药物发现(AIDD)生态的领先定位,维持金斯瑞“增持”评级及目标价41元。(gc/da)(港股报价...
Source Link摩根大通发表研究报告指,礼来(LLY.US) 宣布与金斯瑞生物科技(01548.HK) 等达成TuneLab合作协议,其中金斯瑞将为TuneLab成员公司提供湿实验室服务,包括基因合成、蛋白质表达、净化及按标准化协议进行测试,协助把人工智能生成的药物候选转化为实验结果,认为有助于强化金斯瑞的AI驱动药物发现(AIDD)生态的领先定位,维持金斯瑞“增持”评级及目标价41元。(gc/da)(港股报价...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.